Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder

被引：12

作者：

Tsuma, Yusuke ^{[1
]}

Miyachi, Mitsuru ^{[1
]}

Ouchi, Kazutaka ^{[1
]}

Tsuchiya, Kunihiko ^{[1
]}

Iehara, Tomoko ^{[1
]}

Naitoh, Yasuyuki ^{[2
]}

Konishi, Eiichi ^{[3
]}

Yanagisawa, Akio ^{[3
]}

Hosoi, Hajime ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto, Japan

[2] Kyoto Prefectural Univ Med, Dept Urol, Grad Sch Med Sci, Kyoto, Japan

[3] Kyoto Prefectural Univ Med, Dept Pathol, Kyoto, Japan

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2016年 / 38卷 / 08期

关键词：

inflammatory myofibroblastic tumor; cyclooxygenase-2; neoadjuvant treatment; PLASMA-CELL GRANULOMA; THERAPY; LUNG;

D O I：

10.1097/MPH.0000000000000604

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Inflammatory myofibroblastic tumor (IMT), which expresses cyclooxygenase-2 (COX-2), can be effectively treated with COX-2 inhibitor. Here, we report a case of urinary bladder IMT in a 13-year-old boy. Although total cystectomy was initially planned for complete resection of the tumor, neoadjuvant treatment with COX-2 inhibitor and prednisolone reduced the size of the tumor and enabled complete resection of the tumor by partial cystectomy. Neoadjuvant treatment with COX-2 inhibitor and prednisolone for IMT of the bladder allowed a more conservative surgical procedure that preserved bladder function.

引用

页码：E283 / E285

页数：3

共 50 条

[21] Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase-2 inhibitor
Takizawa, Nae
Matsuzaki, Tomoaki
Yamamoto, Teppei
Mishima, Takao
Miyasaka, Chika
Tanaka, Susumu
Kinoshita, Hidefumi
Uemura, Yoshiko
Yamada, Hisao
Matsuda, Tadashi
INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (08) : 706 - 708
[22] Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
Bensen, WG
Fiechtner, JJ
McMillen, JI
Zhao, WW
Yu, SS
Woods, EM
Hubbard, RC
Isakson, PC
Verburg, KM
Geis, GS
MAYO CLINIC PROCEEDINGS, 1999, 74 (11) : 1095 - 1105
[23] The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis
Miyamoto, K
Oka, N
Kawasaki, T
Satoi, H
Matsuo, A
Akiguchi, I
MUSCLE & NERVE, 1999, 22 (12) : 1704 - 1709
[24] Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor
Anirut Pattaragarn
Uri S. Alon
Pediatric Nephrology, 2003, 18 : 1073 - 1076
[25] Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor
Pattaragarn, A
Alon, US
PEDIATRIC NEPHROLOGY, 2003, 18 (10) : 1073 - 1076
[26] Resection and use of a cyclooxygenase-2 inhibitor for treatment of pancreatic adenocarcinoma in a cockatiel
Chen, S
Bartick, T
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2006, 228 (01): : 69 - 73
[27] NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation
Smakman, N
Schaap, N
Snijckers, CMJT
Rinkes, IHMB
Kranenburg, O
UROLOGY, 2005, 66 (02) : 434 - 440
[28] An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
Jacob, Sanjivini V.
Reith, John D.
Kojima, Angerika Y.
Williams, William D.
Liu, Chen
Duckworth, Lizette Vila
CASE REPORTS IN PATHOLOGY, 2014, 2014
[29] Evaluation of Preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery
Bekker, A
Cooper, PR
Frempong-Boadu, A
Babu, R
Errico, T
Lebovits, A
NEUROSURGERY, 2002, 50 (05) : 1053 - 1057
[30] Celecoxib, a selective cyclooxygenase-2 inhibitor prevents the inflammatory activation acutely induced by smoking
Vlachopoulos, C.
Bratsas, A.
Aznaouridis, K.
Ioakeimidis, N.
Vasiliadou, C.
Tousoulis, D.
Stefanadis, C.
EUROPEAN HEART JOURNAL, 2006, 27 : 785 - 786

← 1 2 3 4 5 →